Product Categories
| Country: | China |
|---|---|
| Tel: | 21-61263452 |
| Mobile: | 13641803416 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Company Name: | Shanghai GL Peptide Ltd |
| Tel: | 86-21-61263385 |
| Fax: | 86-21-61263399 |
| Email: | ymbetter@glbiochem |
| WebSite: | http://www.glbiochem.com |
| Nationality: | CHINA |
| Product Name | MF | CAS | Details |
|---|
| HIV-1 MN ENV-59;CNDKKFSGKGSCKNV | C66H111N21O22S2 | Details |
| HIV-1 MN ENV-6;LGLLMICSATEKLWV | C77H129N17O20S2 | Details |
| HIV-1 MN ENV-61;KGSCKNVSTVQCTHG | C61H105N21O22S2 | Details |
| HIV-1 MN ENV-62;KNVSTVQCTHGIRPV | C69H119N23O21S | Details |
| HIV-1 MN ENV-69;EEVVIRSENFTDNAK | C74H119N21O28 | Details |
| HIV-1 MN ENV-7;MICSATEKLWVTVYY | C84H127N17O23S2 | Details |
| HIV-1 MN ENV-70;IRSENFTDNAKTIIV | C75H125N21O25 | Details |
| HIV-1 MN ENV-71;NFTDNAKTIIVHLNE | C76H121N21O25 | Details |
| HIV-1 MN ENV-72;NAKTIIVHLNESVQI | C74H127N21O23 | Details |
| HIV-1 MN ENV-73;IIVHLNESVQINCTR | C74H127N23O23S | Details |
| HIV-1 MN ENV-75;VQINCTRPNYNKRKR | C79H136N30O22S | Details |
| HIV-1 MN ENV-76;CTRPNYNKRKRIHIG | C79H134N30O20S | Details |
| HIV-1 MN ENV-77;NYNKRKRIHIGPGRA | C77H130N30O19 | Details |
| HIV-1 MN ENV-78;RKRIHIGPGRAFYTT | C80H129N27O19 | Details |
| HIV-1 MN ENV-79;HIGPGRAFYTTKNII | C78H122N22O20 | Details |
| HIV-1 MN ENV-8;ATEKLWVTVYYGVPV | C84H125N17O22 | Details |
| HIV-1 MN ENV-80;GRAFYTTKNIIGTIR | C77H127N23O21 | Details |
| HIV-1 MN ENV-82;NIIGTIRQAHCNISR | C70H122N26O21S | Details |
| HIV-1 MN ENV-83;TIRQAHCNISRAKWN | C76H124N28O21S | Details |
| HIV-1 MN ENV-84;AHCNISRAKWNDTLR | C75H121N27O22S | Details |
| HIV-1 MN ENV-85;ISRAKWNDTLRQIVS | C78H131N25O23 | Details |
| HIV-1 MN ENV-86;KWNDTLRQIVSKLKE | C83H140N24O24 | Details |
| HIV-1 MN ENV-87;TLRQIVSKLKEQFKN | C82H142N24O23 | Details |
| HIV-1 MN ENV-88;IVSKLKEQFKNKTIV | C82H143N21O22 | Details |
| HIV-1 MN ENV-90;FKNKTIVFNQSSGGD | C72H112N20O24 | Details |
| HIV-1 MN ENV-91;TIVFNQSSGGDPEIV | C68H107N17O25 | Details |
| HIV-1 MN ENV-92;NQSSGGDPEIVMHSF | C67H101N19O25S | Details |
| HIV-1 MN ENV-93;GGDPEIVMHSFNCGG | C63H94N18O22S2 | Details |
| HIV-1 MN ENV-95;HSFNCGGEFFYCNTS | C75H97N19O24S2 | Details |
| HIV-1 MN ENV-97;FFYCNTSPLFNSTWN | C87H113N19O24S | Details |
| HIV-1 MN ENV-98;NTSPLFNSTWNGNNT | C71H103N21O26 | Details |
| HIV-1 MN ENV-99;LFNSTWNGNNTWNNT | C78H107N23O26 | Details |
| HIV-1 MN gp160 Fragment 04;EKLWVYYGVPVWKEATTT | C105H152N22O28 | Details |
| HIV-1 MN ENV-26;EQMHEDIISLWDQSL | C80H122N20O28S | Details |
| HIV-1 MN ENV-3;NYQHWWGWGTMLLGL | C90H120N22O20S | Details |
| HIV-1 MN ENV-32;CVTLNCTDLRNTTNT | C65H113N21O26S2 | Details |
| HIV-1 MN ENV-33;NCTDLRNTTNTNNST | C62H105N23O29S | Details |
| HIV-1 MN ENV-34;LRNTTNTNNSTANNN | C62H105N25O28 | Details |
| HIV-1 MN ENV-35;TNTNNSTANNNSNSE | C57H92N22O31 | Details |
| HIV-1 MN ENV-36;NSTANNNSNSEGTIK | C59H99N21O28 | Details |
| HIV-1 MN ENV-37;NNNSNSEGTIKGGEM | C59H98N20O27S | Details |
| HIV-1 MN ENV-38;NSEGTIKGGEMKNCS | C60H103N19O25S2 | Details |
| HIV-1 MN ENV-39;TIKIGGEMKNCSFNIT | C75H126N20O24S2 | Details |
| HIV-1 MN ENV-4;WWGWGTMLLGLLMIC | C86H126N18O17S3 | Details |
| HIV-1 MN ENV-40;GEMKNCSFNITTSIR | C70H117N21O24S2 | Details |
| HIV-1 MN ENV-41;NCSFNITTSIRDKMQ | C72H120N22O25S2 | Details |
| HIV-1 MN ENV-42;NITTSIRDKMQKEYA | C76H128N22O26S | Details |
| HXB2 gag #103;RKKGCWKCGKEGHQM | Details |
| Human prepro-gamma-tryptase (192-206);CRRDYPGPGGSILQP | C69H110N22O21S | Details |
| HIV-1 MN ENV-21;QEVELVNVTENFNMW | C82H122N20O27S | Details |
| HIV-1 MN ENV-210;GRAILHIPTRIRQGL | C75H133N27O18 | Details |
| HIV-1 MN ENV-212;TRIRQGLERALL | C61H112N22O17 | Details |
| HIV-1 MN ENV-22;LVNVTENFNMWKNNM | C81H124N22O24S2 | Details |
| HIV-1 MN ENV-23;TENFNMWKNNMVEQM | C81H122N22O26S3 | Details |
| HIV-1 MN ENV-24;NMWKNNMVEQMHEDI | C80H123N23O26S3 | Details |
| HIV-1 MN ENV-25;NNMVEQMHEDIISLW | C80H123N21O26S2 | Details |
| HMGA N-Terminal Fragment;GAGQPSTSAQGQ | C42H69N15O19 | Details |
| HIV-1 Protease Substrate, chromogenic;Ac-RKILF(4-NO2)LDG-NH2 | C47H78N14O13 | Details |
| HIV-1 MN gp160 Fragment 17;NDSTSYRLISCNTSV | C67H110N20O27S | Details |
| HIV-1 MN gp160 Fragment 16;LYKLDIVSIDNDSTSYRLIS | C103H167N25O35 | Details |
| HIV-1 MN gp160 Fragment 15;REKMQKEYALLYKLDIVSID | C111H183N27O33S | Details |
| HIV-1 MN gp160 Fragment 08;NFNMWKNNMVEQMHEDIISK | C108H166N30O33S3 | Details |
| HIV-1 MN gp160 Fragment 07;ELVNVTENFNMWK | C73H110N18O22S | Details |
| HIV-1 MN ENV-46;LYKLDIVSIDNDSTS | C73H119N17O28 | Details |
| HIV-1 MN ENV-48;IDNDSTSYRLISCNT | C69H112N20O28S | Details |
| HIV-1 MN ENV-5;GTMLLGLLMICSATE | C66H117N15O21S3 | Details |
| HIV-1 MN ENV-50;RLISCNTSVITQACP | C66H116N20O22S2 | Details |
| HIV-1 MN ENV-51;CNTSVITQACPKISF | C69H114N18O22S2 | Details |
| HIV-1 MN ENV-52;VITQACPKISFEPIP | C76H123N17O21S | Details |
| HIV-1 MN ENV-53;ACPKISFEPIPIHYC | C80H120N18O20S2 | Details |
| HIV-1 MN ENV-56;HYCAPAGFAILKCND | C72H107N19O20S2 | Details |
| HIV-1 MN ENV-58;AILKCNDKKFSGKGS | C69H118N20O21S | Details |
| HIV-1 MN gp160 Fragment 02;LLMICSAT | C36H66N8O11S2 | Details |
| HIV-1 MN ENV-57;PAGFAILKCNDKKFS | C75H119N19O20S | Details |
| HIV-1 MN ENV-54;ISFEPIPIHYCAPAG | C76H111N17O20S | Details |
| HIV-1 MN ENV-49;STSYRLISCNTSVIT | C69H117N19O25S | Details |
| HIV-1 MN ENV-47;DIVSIDNDSTSYRLI | C73H119N19O28 | Details |
| HIV-1 MN ENV-45;EYALLYKLDIVSIDN | C82H129N17O26 | Details |
| HIV-1 MN ENV-44;KMQKEYALLYKLDIV | C87H143N19O23S | Details |
| HIV-1 MN gp160 Fragment 05;VPVWKEATTTLFCASDAKAY | C101H153N23O30S | Details |
| H-Phe-Arg-AFC;FR-AFC | C25H27F3N6O4 | Details |
| HIV-1 MN ENV-211;LHIPTRIRQGLERAL | C78H137N27O20 | Details |
| H-Tyr-Val-Ala-Asp-AFC;YVAD-AFC | C31H34F3N5O9 | Details |
| Human Myocilin/TIGR Fragment (188-204);TRDTARAVPPGSREVST | C73H126N26O27 | Details |
| HXB2 gag #1/aa1-15;MGARASVLSGGELDR | Details |
| HXB2 gag #10;ASRELERFAVNPGLL | Details |
| HXB2 gag #100/aa397-411;KEGHTARNCRAPRKK | C71H126N30O20S | Details |
| HXB2 gag #101/aa401-415;TARNCRAPRKKGCWK | C74H127N29O18S2 | Details |
| HXB2 gag #102/aa405-419;CRAPRKKGCWKCGKE | C73H124N26O18S3 | Details |
| HIV-1 MN ENV-43;SIRDKMQKEYALLYK | C85H140N22O24S | Details |
| HIV-1 MN ENV-31;LTPLCVTLNCTDLRN | C70H122N20O23S2 | Details |
| HIV-1 MN ENV-30;PCVKLTPLCVTLNCT | C69H121N17O20S3 | Details |
| HIV-1 MN gp160 Fragment 03;CSATEKLWV | C46H73N11O14S | Details |
| HIV-1 MN ENV-96;CGGEFFYCNTSPLFN | C77H103N17O23S2 | Details |
| HIV-1 MN ENV-94;EIVMHSFNCGGEFFY | C82H110N18O23S2 | Details |
| HIV-1 MN ENV-89;LKEQFKNKTIVFNQS | C83H134N22O24 | Details |
| HIV-1 MN ENV-81;YTTKNIIGTIRQAHC | C74H123N23O22S | Details |
| HIV-1 MN ENV-74;LNESVQINCTRPNYN | C73H117N23O26S | Details |
| HIV-1 MN ENV-68;SLAEEEVVIRSENFT | C74H119N19O28 | Details |
| HIV-1 MN ENV-60;KFSGKGSCKNVSTVQ | C66H112N20O22S | Details |
| Product Total： Product Page： | ||||
| 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 | ||||